ThrombocytopeniaLeukopeniaPlatelet CountPurpura, Thrombocytopenic, IdiopathicThrombocytopenia, Neonatal AlloimmunePlatelet TransfusionBlood PlateletsAntineoplastic Combined Chemotherapy ProtocolsDrug Administration ScheduleAntigens, Human PlateletDrug EvaluationPurpura, ThrombocytopenicMegakaryocytesThrombopoietinPhlebovirusPlatelet Factor 4NeutropeniaTreatment OutcomeCisplatinInfusions, IntravenousReceptors, ThrombopoietinLeukocyte CountHeparinHematologic DiseasesBunyaviridae InfectionsBlood Cell CountSplenectomyCarboplatinThrombopoiesisDisseminated Intravascular CoagulationDeoxycytidinePregnancy Complications, HematologicFluorouracilAnemiaAntineoplastic AgentsPaclitaxelPipecolic AcidsBone MarrowHemorrhageDose-Response Relationship, DrugDoxorubicinCyclophosphamideImmunoglobulins, IntravenousLung NeoplasmsMaximum Tolerated DoseSurvival AnalysisBone Marrow DiseasesNauseaCombined Modality TherapyEtoposidePurpura, Thrombotic ThrombocytopenicPancytopeniaGranulocyte Colony-Stimulating FactorNeoplasmsWiskott-Aldrich SyndromeAnticoagulantsAntineoplastic Agents, PhytogenicSurvival RateVinblastineTaxoidsBlood Platelet DisordersEhrlichiosisRetrospective StudiesTime FactorsCamptothecinDisease-Free SurvivalSalvage TherapyAntimetabolites, AntineoplasticHemorrhagic DisordersOrganoplatinum CompoundsFeverSplenomegalyAutoantibodiesIfosfamideAntineoplastic Agents, AlkylatingRemission InductionRecombinant ProteinsEhrlichiaVomitingTopotecanDacarbazineAntibodies, MonoclonalHemolytic-Uremic SyndromeThrombocytosisIsoantibodiesThrombosisLeucovorinRecurrenceNeoplasm Recurrence, LocalCarcinoma, Non-Small-Cell LungAlopeciaCarcinoma, Small CellAgranulocytosisProspective StudiesAdministration, OralHypersplenismInterleukin-11LeukocytesHematopoiesisVincristine